Plain-English translation of NCT06236607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing three different hybrid closed loop (HCL) insulin pump systems in adults with type 1 diabetes. These are small devices that automatically deliver insulin based on your blood sugar readings throughout the day and night, similar to how a healthy pancreas would work. The trial wants to see if these automated pumps help people — especially those from communities that have been historically underserved — manage their diabetes better than traditional insulin injections.
Adults with type 1 diabetes from underserved communities often have higher blood sugar levels and more serious complications than others with the same condition. Earlier studies showed that automated insulin pumps work well, but those studies mostly included people from more advantaged backgrounds. This trial aims to see if this treatment works just as well for everyone, and to understand what barriers or challenges people might face using these devices.
You likely qualify if…
You likely don't qualify if…
If you are randomly assigned to use one of the automated pump systems, you'll wear a small device on your body that automatically delivers insulin based on readings from a glucose monitor. You'll be followed for 9 months with regular check-ins to see how well the pump is working, how safe it is, and how it fits into your daily life. If you're assigned to the comparison group, you'll continue using multiple daily injections as you currently do. Throughout the study, researchers will ask about your experience, any challenges you face, and how the technology affects your quality of life.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States